Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cyclobenzaprine capsule

A technology for cyclobenzaprine and benzalkonium is applied in the field of medicine and achieves the effects of simple preparation process and stable product quality

Inactive Publication Date: 2020-08-07
CP PHARMA QINGDAO CO LTD +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cyclobenzaprine was first developed by Merk Company. Cyclobenzaprine hydrochloride tablets were launched in the U.S. under the trade name: Flexeril®, with specifications of 5mg and 10mg. One of the most commonly used muscle relaxants, but it has not been marketed in China

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cyclobenzaprine capsule
  • Cyclobenzaprine capsule
  • Cyclobenzaprine capsule

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0024] A preparation method of cyclobenzaprine enteric-coated capsules, comprising the following steps:

[0025] (1) Get cyclobenzaprine and filler to mix evenly, take 85% ethanol as binder, make 20-30 object cyclobenzaprine pellets, for subsequent use;

[0026] (2) Dissolve enteric-coated material, plasticizer and lubricant with 80% ethanol, make enteric-coated liquid;

[0027] (3) Evenly spray the enteric coating solution prepared in step (2) on the surface of the cyclobenzaprine pellets prepared in step (1), and obtain cyclobenzaprine enteric-coated pellets after drying;

[0028] (4) Filling cyclobenzaprine enteric-coated pellets into capsule shells to obtain cyclobenzaprine enteric-coated capsules.

Embodiment 1-6

[0029] Example 1-6 Preparation of Cyclobenzaprine Enteric-Coated Capsules

[0030] Cyclobenzaprine enteric-coated capsules were prepared according to the raw and auxiliary materials in the following prescription and the above-mentioned preparation method. Among them, " / " means not used.

[0031]

Embodiment 7-11

[0040] Example 7-11 Preparation of cyclobenzaprine enteric-coated capsules

[0041] Cyclobenzaprine enteric-coated capsules were prepared according to the raw and auxiliary materials in the following prescription and the above-mentioned preparation method.

[0042]

[0043] Test Example 2 Determination of Dissolution of Cyclobenzaprine Enteric-Coated Capsules Gained in Examples 7-11

[0044] The measurement method is the same as that of Test Example 1, and the measurement results are shown in Table 3 and Table 4.

[0045] Table 3 Dissolution of cyclobenzaprine enteric-coated capsules obtained in Examples 7-11 in artificial gastric juice

[0046]

[0047] As can be seen from Table 3, the cyclobenzaprine enteric-coated capsule of embodiment 8 dissolves the slowest in the pH1.2 artificial gastric juice, indicating that when the weight of the enteric-coated material methacrylic acid copolymer and hydroxypropyl methylcellulose phthalate When the ratio is 2:1, the prepared c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cyclobenzaprine enteric capsule and a preparation method thereof. The cyclobenzaprine enteric capsule disclosed by the invention is prepared by loading cyclobenzaprine enteric pellets into a capsule shell, the cyclobenzaprine enteric pellet is composed of a cyclobenzaprine pellet and an enteric coating layer wrapping the cyclobenzaprine pellet, the cyclobenzaprine pelletcomprises cyclobenzaprine and filler, the enteric coating layer comprises an enteric material, a plasticizer and a lubricant, and the preparation method includes: wrapping the cyclobenzaprine pellet with the enteric coating layer and then loading the product into a capsule to obtain the cyclobenzaprine enteric capsule. The cyclobenzaprine enteric capsule provided by the invention is convenient totake, the enteric effect is ideal, the bioavailability of cyclobenzaprine is improved, the preparation process is simple, the obtained product is stable in quality and is suitable for large-scale production.

Description

technical field [0001] The invention relates to a western medicine preparation technology, in particular to a cyclobenzaprine enteric-coated capsule, which belongs to the technical field of medicine. Background technique [0002] Musculoskeletal system diseases are more common in clinical practice, involving bones, intervertebral discs, nerves, muscles, joints, soft tissues and other diseases. There are also many causes of musculoskeletal pain, such as inflammation, mechanical injury, immune reasons, tumors, etc. The International Society for Pain (IASP) pointed out that musculoskeletal pain is the pain with the highest incidence and the largest range of impact among all pains, and even about half of the population suffers from musculoskeletal pain for more than 3 months in a year. Musculoskeletal pain occurs frequently and is classified into neck pain, back and lower back pain, joint pain, etc. depending on the site of attack. Often cause long-term, chronic injury to the p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/50A61K47/38A61K47/32A61K31/135A61P21/02
CPCA61K9/5026A61K9/5047A61K31/135A61P21/02
Inventor 臧云龙袁航陈阳生孙桂玉刘晓霞王明刚刘振玉赵铭良薛文静邱传龙
Owner CP PHARMA QINGDAO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com